{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:58:51Z","timestamp":1790441931520,"version":"4.1.0"},"reference-count":73,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100019803","name":"Oklahoma State University Center for Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019803","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Office of Research and Department of Pharmacology and Physiology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study evaluates whether PAM-4, a positive allosteric modulator of the \u03b17 nicotinic acetylcholine receptor, can reverse neuropathic pain and associated affective disturbances caused by oxaliplatin (OXA) in male mice and whether they are linked to alterations in cytokine\/chemokine and brain-derived neurotrophic factor (BDNF) levels in different central nervous system (CNS) areas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Mice were first treated with OXA to induce neuropathic pain and associated anxiety- and depressive-like symptoms in mice, and the activity of PAM-4 subsequently determined. Cytokine\/chemokine and BDNF levels were also assessed in various CNS areas dissected from treated animals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>The behavioral results indicated that PAM-4 significantly alleviated neuropathic pain and comorbidities induced by OXA. Concurrently, PAM-4 diminished OXA-induced increase in chemokine\/cytokine levels across multiple tissues, especially in the spinal cord and hippocampus. Furthermore, PAM-4 restored the levels of pro BDNF and mature BDNF in the spinal cord and brain. Most effects mediated by PAM-4 were attenuated by the selective antagonist methyllycaconitine (MLA), whereas MLA alone also reduced the effects of OXA in few cases, suggesting that although \u03b17 nAChR potentiation is the primary mechanism, receptor inhibition may also play a role.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\u03b17 nAChR modulation effectively alleviates neuropathic pain and associated comorbidities induced by chemotherapy, along with a decrease in neuroinflammatory markers and rebalancing of BDNF signaling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jpp\/rgag106","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T11:20:13Z","timestamp":1788693613000},"source":"Crossref","is-referenced-by-count":0,"title":["\u03b17 nicotinic acetylcholine receptor potentiation modulates cytokine\/chemokines and brain derived neurotrophic factor in the central nervous system of mice: implications in decreased neuropathic pain and associated comorbidities"],"prefix":"10.1093","volume":"78","author":[{"given":"Ilias","family":"Marmouzi","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Physiology, Oklahoma State University - Center for Health Sciences , Tulsa, OK 74107 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall L","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, Oklahoma State University - Center for Health Sciences , Tulsa, OK 74107 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2764-1927","authenticated-orcid":false,"given":"Hugo R","family":"Arias","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, Oklahoma State University - Center for Health Sciences , Tulsa, OK 74107 ,","place":["United States"]},{"name":"Department of Pharmacology and Physiology, Oklahoma State University - College of Osteopathic Medicine , Tahlequah, OK 74107 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"key":"2026092612203774100_ref1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1152\/physrev.00045.2019","article-title":"Neuropathic pain: from mechanisms to treatment","volume":"101","author":"Finnerup","year":"2021","journal-title":"Physiol Rev"},{"key":"2026092612203774100_ref2","doi-asserted-by":"publisher","first-page":"9724371","DOI":"10.1155\/2017\/9724371","article-title":"The link between depression and chronic pain: neural mechanisms in the brain","volume":"2017","author":"Sheng","year":"2017","journal-title":"Neural Plast"},{"key":"2026092612203774100_ref3","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/j.pain.0000000000003056","article-title":"Co-occurrence of chronic pain and anxiety\/depression symptoms in U.S. adults: prevalence, functional impacts, and opportunities","volume":"165","author":"De La Rosa","year":"2024","journal-title":"Pain"},{"key":"2026092612203774100_ref4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1021\/acsmedchemlett.3c00520","article-title":"Positive allosteric modulators of alpha7 nicotinic acetylcholine receptor for the treatment of several central nervous system diseases","volume":"15","author":"Abdel-Magid","year":"2024","journal-title":"ACS Med Chem Lett"},{"key":"2026092612203774100_ref5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/J.BBR.2019.03.019","article-title":"Alpha-7 nicotinic receptor allosteric modulator PNU120596 prevents lipopolysaccharide-induced anxiety, cognitive deficit and depression-like behaviors in mice","volume":"366","author":"Alzarea","year":"2019","journal-title":"Behav Brain Res"},{"key":"2026092612203774100_ref6","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1080\/01616412.2021.1949684","article-title":"(E)-3-furan-2-yl-N-phenylacrylamide (PAM-4) decreases nociception and emotional manifestations of neuropathic pain in mice by \u03b17 nicotinic acetylcholine receptor potentiation","volume":"43","author":"Bagdas","year":"2021","journal-title":"Neurol Res"},{"key":"2026092612203774100_ref7","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3390\/MOLECULES28031270","article-title":"Recent advances in the discovery of nicotinic acetylcholine receptor allosteric modulators","volume":"28","author":"Manetti","year":"2023","journal-title":"Molecules"},{"key":"2026092612203774100_ref8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/07391102.2018.1427634","article-title":"Molecular interactions of type I and type II positive allosteric modulators with the human \u03b17 nicotinic acetylcholine receptor: an in silico study","volume":"37","author":"Targowska-Duda","year":"2019","journal-title":"J Biomol Struct Dyn"},{"key":"2026092612203774100_ref9","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/J.PHAREP.2019.07.001","article-title":"The \u03b17 nicotinic acetylcholine receptor positive allosteric modulator prevents lipopolysaccharide-induced allodynia, hyperalgesia and TNF-\u03b1 in the hippocampus in mice","volume":"71","author":"Abbas","year":"2019","journal-title":"Pharmacol Rep"},{"key":"2026092612203774100_ref10","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1021\/acschemneuro.0c00476","article-title":"(E)-3-Furan-2-yl- N- p-tolyl-acrylamide and its derivative DM489 decrease neuropathic pain in mice predominantly by \u03b17 nicotinic acetylcholine receptor potentiation","volume":"11","author":"Arias","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"2026092612203774100_ref11","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1213\/ANE.0000000000006461","article-title":"The antinociceptive activity of (E)-3-(thiophen-2-yl)-N-(p-tolyl)acrylamide in mice is reduced by (E)-3-(furan-2-yl)-N-methyl-N-(p-tolyl)acrylamide through opposing modulatory mechanisms at the \u03b17 nicotinic acetylcholine receptor","volume":"137","author":"Arias","year":"2023","journal-title":"Anesth Analg"},{"key":"2026092612203774100_ref12","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1213\/ANE.0000000000000902","article-title":"The antinociceptive and antiinflammatory properties of 3-furan-2-yl-Np-tolyl-acrylamide, a positive allosteric modulator of \u03b17 nicotinic acetylcholine receptors in mice","volume":"121","author":"Bagdas","year":"2015","journal-title":"Anesth Analg"},{"key":"2026092612203774100_ref13","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1177\/0269881118821100","article-title":"3-Furan-2-yl-N-p-tolyl-acrylamide, a highly selective positive allosteric modulator of \u03b17 nicotinic receptors, produces anxiolytic-like activity in mice","volume":"33","author":"Targowska-Duda","year":"2019","journal-title":"J Psychopharmacol"},{"key":"2026092612203774100_ref14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/J.EURONEURO.2021.06.006","article-title":"Type I and type II positive allosteric modulators of \u03b17 nicotinic acetylcholine receptors induce antidepressant-like activity in mice by a mechanism involving receptor potentiation but not neurotransmitter reuptake inhibition. Correlation with mTOR intracellular pathway activation","volume":"52","author":"Targowska-Duda","year":"2021","journal-title":"Eur Neuropsychopharmacol"},{"key":"2026092612203774100_ref15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bbr.2016.01.002","article-title":"The positive allosteric modulator of \u03b17 nicotinic acetylcholine receptors, 3-furan-2-yl-N-p-tolyl-acrylamide, enhances memory processes and stimulates ERK1\/2 phosphorylation in mice","volume":"302","author":"Targowska-Duda","year":"2016","journal-title":"Behav Brain Res"},{"key":"2026092612203774100_ref16","doi-asserted-by":"publisher","first-page":"970040","DOI":"10.3389\/FNMOL.2022.970040","article-title":"Targeting \u03b17 nicotinic acetylcholine receptors for chronic pain","volume":"15","author":"Zhou","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"2026092612203774100_ref17","doi-asserted-by":"publisher","first-page":"106405","DOI":"10.1016\/J.BIOCEL.2023.106405","article-title":"\u03b17 nicotinic acetylcholine receptor potentiation downregulates chemotherapy-induced inflammatory overactivation by overlapping intracellular mechanisms","volume":"158","author":"Marmouzi","year":"2023","journal-title":"Int J Biochem Cell Biol"},{"key":"2026092612203774100_ref18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12974-017-0967-6\/FIGURES\/8","article-title":"Anti-inflammatory effects of astroglial \u03b17 nicotinic acetylcholine receptors are mediated by inhibition of the NF-\u039aB pathway and activation of the Nrf2 pathway","volume":"14","author":"Patel","year":"2017","journal-title":"J Neuroinflammation"},{"key":"2026092612203774100_ref19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/7854_2020_135","article-title":"Behavioral and molecular basis of cholinergic modulation of pain: focus on nicotinic acetylcholine receptors","volume":"45","author":"Toma","year":"2020","journal-title":"Curr Top Behav Neurosci"},{"key":"2026092612203774100_ref20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.expneurol.2014.06.016","article-title":"Glial role in oxaliplatin-induced neuropathic pain","volume":"261","author":"Mannelli","year":"2014","journal-title":"Exp Neurol"},{"key":"2026092612203774100_ref21","doi-asserted-by":"publisher","first-page":"643824","DOI":"10.3389\/fmolb.2021.643824","article-title":"Oxaliplatin-induced neuropathy: genetic and epigenetic profile to better understand how to ameliorate this side effect","volume":"8","author":"Branca","year":"2021","journal-title":"Front Mol Biosci"},{"key":"2026092612203774100_ref22","doi-asserted-by":"publisher","first-page":"5263","DOI":"10.1021\/bi102001m","article-title":"Novel positive allosteric modulators of the human \u03b17 nicotinic acetylcholine receptor","volume":"50","author":"Arias","year":"2011","journal-title":"Biochemistry"},{"key":"2026092612203774100_ref23","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1111\/bph.13528","article-title":"The \u03b17 nicotinic receptor dual allosteric agonist and positive allosteric modulator GAT107 reverses nociception in mouse models of inflammatory and neuropathic pain","volume":"173","author":"Bagdas","year":"2016","journal-title":"Br J Pharmacol"},{"key":"2026092612203774100_ref24","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/978-3-540-68706-1_150","volume-title":"Encyclopedia of Psychopharmacology","author":"P\u00e1dua Carobrez","year":"2010"},{"key":"2026092612203774100_ref25","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/s0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"2026092612203774100_ref26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/J.NEULET.2011.08.053","article-title":"Chronic inorganic mercury exposure induces sex-specific changes in central TNF\u03b1 expression: importance in autism?","volume":"504","author":"Thomas Curtis","year":"2011","journal-title":"Neurosci Lett"},{"key":"2026092612203774100_ref27","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1111\/J.1530-0277.2002.TB02685.X","article-title":"Ethanol-induced modulation of inducible nitric-oxide synthase activity in human A172 astrocytoma cells","volume":"26","author":"Davis","year":"2002","journal-title":"Alcohol Clin Exp Res"},{"key":"2026092612203774100_ref28","doi-asserted-by":"publisher","first-page":"117887","DOI":"10.1016\/j.biopha.2025.117887","article-title":"Ibogalogs decrease neuropathic pain in mice through a mechanism involving crosstalk between the 5-HT2A and mGlu2 receptors","volume":"184","author":"Arias","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"2026092612203774100_ref29","doi-asserted-by":"publisher","first-page":"104863","DOI":"10.1016\/j.jpain.2025.104863","article-title":"Investigating the role of the \u03b17 nicotinic acetylcholine receptor in myeloid lineage cells in chronic neuropathic and inflammatory pain","volume":"29","author":"Swift","year":"2025","journal-title":"J Pain"},{"key":"2026092612203774100_ref30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuropharm.2013.10.034","article-title":"Involvement of alpha7 nAChR subtype in rat oxaliplatin-induced neuropathy: effects of selective activation","volume":"79","author":"Di Cesare","year":"2014","journal-title":"Neuropharmacology"},{"key":"2026092612203774100_ref31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2147\/JPR.S286321","article-title":"The spinal \u03b17-nicotinic acetylcholine receptor contributes to the maintenance of cancer-induced bone pain","volume":"14","author":"Yang","year":"2021","journal-title":"J Pain Res"},{"key":"2026092612203774100_ref32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neuroscience.2020.12.027","article-title":"The nAChR chaperone TMEM35a (NACHO) contributes to the development of hyperalgesia in mice","volume":"457","author":"Khasabov","year":"2021","journal-title":"Neurosci"},{"key":"2026092612203774100_ref33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neuroscience.2016.12.029","article-title":"Spinal activation of alpha7-nicotinic acetylcholine receptor attenuates posttraumatic stress disorder-related chronic pain via suppression of glial activation","volume":"344","author":"Sun","year":"2017","journal-title":"Neurosci"},{"key":"2026092612203774100_ref34","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.bbi.2010.03.008","article-title":"Intrathecal injection of an alpha seven nicotinic acetylcholine receptor agonist attenuates gp120-induced mechanical allodynia and spinal pro-inflammatory cytokine profiles in rats","volume":"24","author":"Loram","year":"2010","journal-title":"Brain Behav Immun"},{"key":"2026092612203774100_ref35","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.jpain.2012.08.009","article-title":"Systemic administration of an alpha-7 nicotinic acetylcholine agonist reverses neuropathic pain in male Sprague Dawley rats","volume":"13","author":"Loram","year":"2012","journal-title":"J Pain"},{"key":"2026092612203774100_ref36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1744806917704769","article-title":"Activation of spinal alpha-7 nicotinic acetylcholine receptor shortens the duration of remifentanil-induced postoperative hyperalgesia by upregulating KCC2 in the spinal dorsal horn in rats","volume":"13","author":"Gu","year":"2017","journal-title":"Mol Pain"},{"key":"2026092612203774100_ref37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.brainres.2019.03.016","article-title":"Activation of alpha7 acetylcholine receptors reduces neuropathic pain by decreasing dynorphin a release from microglia","volume":"1715","author":"Ji","year":"2019","journal-title":"Brain Res"},{"key":"2026092612203774100_ref38","doi-asserted-by":"publisher","first-page":"000231","DOI":"10.23880\/apct-16000231","article-title":"Pretreatment with nicotine improves behavioral recovery and ameliorates neuroinflammation in a rat model of spinal cord injury","volume":"9","author":"Badripour","year":"2024","journal-title":"Adv Pharmacol Clin Trials"},{"key":"2026092612203774100_ref39","first-page":"1871","article-title":"Activation of spinal alpha-7 nicotinic acetylcholine receptor attenuates remifentanil-induced postoperative hyperalgesia","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"2026092612203774100_ref40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12264-017-0106-5","article-title":"Spinal CCL2 promotes central sensitization, long-term potentiation, and inflammatory pain via CCR2: further insights into molecular, synaptic, and cellular mechanisms","volume":"34","author":"Xie","year":"2018","journal-title":"Neurosci Bull"},{"key":"2026092612203774100_ref41","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jpain.2010.01.271","article-title":"Pain intensity and duration can be enhanced by prior challenge: initial evidence suggestive of a role of microglial priming","volume":"11","author":"Hains","year":"2010","journal-title":"J Pain"},{"key":"2026092612203774100_ref42","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/J.BCP.2015.07.032","article-title":"Anti-inflammatory role of microglial alpha7 nAChRs and its role in neuroprotection","volume":"97","author":"Egea","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"2026092612203774100_ref43","doi-asserted-by":"publisher","first-page":"100227","DOI":"10.3748\/wjg.v31.i8.100227","article-title":"Mechanism of Wuling powder modulating proBDNF\/p75NTR\/sortilin and BDNF\/TrkB pathways in the treatment of ulcerative colitis complicated with depression","volume":"31","author":"Wang","year":"2025","journal-title":"World J Gastroenterol"},{"key":"2026092612203774100_ref44","doi-asserted-by":"publisher","first-page":"206","DOI":"10.5582\/ddt.2017.01038","article-title":"The \u03b17 nicotinic acetylcholine receptor positive allosteric modulator attenuates lipopolysaccharide-induced activation of hippocampal I\u03baB and CD11b gene expression in mice","volume":"11","author":"Abbas","year":"2017","journal-title":"Drug Discov Ther"},{"key":"2026092612203774100_ref45","doi-asserted-by":"publisher","first-page":"366","DOI":"10.2174\/1871527319666201230102616","article-title":"Effects of \u03b17 nicotinic acetylcholine receptor positive allosteric modulator on BDNF, NKCC1 and KCC2 expression in the hippocampus following lipopolysaccharide-induced allodynia and hyperalgesia in a mouse model of inflammatory pain","volume":"20","author":"Abbas","year":"2021","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2026092612203774100_ref46","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.2147\/JPR.S159146","article-title":"\u03b17 nicotinic acetylcholine receptor-mediated anti-inflammatory effect in a chronic migraine rat model via the attenuation of glial cell activation","volume":"11","author":"Liu","year":"2018","journal-title":"J Pain Res"},{"key":"2026092612203774100_ref47","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1523\/JNEUROSCI.16-09-02956.1996","article-title":"Regulation of alpha7 nicotinic acetylcholine receptors in the developing rat somatosensory cortex by thalamocortical afferents","volume":"16","author":"Broide","year":"1966","journal-title":"J Neurosci"},{"key":"2026092612203774100_ref48","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.3390\/cells11142195","article-title":"Activation of the \u03b17 nicotinic acetylcholine receptor prevents against microglial-induced inflammation and insulin resistance in hypothalamic neuronal cells","volume":"11","author":"Amaral","year":"2022","journal-title":"Cells"},{"key":"2026092612203774100_ref49","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12974-024-03287-1","article-title":"Localization of brain neuronal IL-1R1 reveals specific neural circuitries responsive to immune signaling","volume":"21","author":"Nemeth","year":"2024","journal-title":"J Neuroinflammation"},{"key":"2026092612203774100_ref50","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1007\/s12035-023-03881-z","article-title":"CCL2 potentiates inflammation pain and related anxiety-like behavior through NMDA signaling in anterior cingulate cortex","volume":"61","author":"Guo","year":"2024","journal-title":"Mol Neurobiol"},{"key":"2026092612203774100_ref51","doi-asserted-by":"publisher","first-page":"1365210","DOI":"10.1155\/2019\/1365210","article-title":"Interleukin-6 expression by hypothalamic microglia in multiple inflammatory contexts: a systematic review","volume":"2019","author":"Bobbo","year":"2019","journal-title":"Biomed Res Int"},{"key":"2026092612203774100_ref52","doi-asserted-by":"publisher","first-page":"872155","DOI":"10.3389\/fimmu.2022.872155","article-title":"What is IL-1 for? The functions of interleukin-1 across evolution","volume":"13","author":"Boraschi","year":"2022","journal-title":"Front Immunol"},{"key":"2026092612203774100_ref53","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/jnc.12827","article-title":"Stimulatory role of the chemokine CCL2 in the migration and peptide expression of embryonic hypothalamic neurons","volume":"131","author":"Poon","year":"2014","journal-title":"J Neurochem"},{"key":"2026092612203774100_ref54","doi-asserted-by":"publisher","first-page":"109338","DOI":"10.1016\/j.cellsig.2019.06.003","article-title":"Antagonizing \u03b17 nicotinic receptors with methyllycaconitine (MLA) potentiates receptor activity and memory acquisition","volume":"62","author":"Goethem","year":"2019","journal-title":"Cel Signalling"},{"key":"2026092612203774100_ref55","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1111\/bph.13769","article-title":"Hippocampal \u03b17 nicotinic ACh receptors contribute to modulation of depression-like behaviour in C57BL\/6J mice","volume":"175","author":"Mineur","year":"2018","journal-title":"Br J Pharmacol"},{"key":"2026092612203774100_ref56","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/mp.2017.145","article-title":"Nicotinic receptors mediate stress-nicotine detrimental interplay via dopamine cells' activity","volume":"23","author":"Morel","year":"2018","journal-title":"Mol Psychiatry"},{"key":"2026092612203774100_ref57","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.biopsych.2019.12.013","article-title":"Cholinergic modulation of disorderrelevant neural circuits in generalized anxiety disorder","volume":"87","author":"Wise","year":"2020","journal-title":"Biol Psychiatry"},{"key":"2026092612203774100_ref58","doi-asserted-by":"publisher","first-page":"109836","DOI":"10.1016\/j.neuropharm.2024.109836","article-title":"BNC210, a negative allosteric modulator of the alpha 7 nicotinic acetylcholine receptor, demonstrates anxiolytic- and antidepressant-like effects in rodents","volume":"246","author":"O'Connor","year":"2024","journal-title":"Neuropharmacology"},{"key":"2026092612203774100_ref59","doi-asserted-by":"publisher","first-page":"107122","DOI":"10.1016\/j.nbd.2025.107122","article-title":"\u03b17 nicotinic acetylcholine receptor and depression: mechanistic insights and therapeutic prospects","volume":"216","author":"Wang","year":"2025","journal-title":"Neurobiol Dis"},{"key":"2026092612203774100_ref60","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2174\/1570159X22666240528161117","article-title":"The role of alpha-7 nicotinic acetylcholine receptors in pain: potential therapeutic implications","volume":"23","author":"Tao","year":"2025","journal-title":"Curr Neuropharmacol"},{"key":"2026092612203774100_ref61","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.mcn.2006.08.011","article-title":"BDNF up-regulates alpha7 nicotinic acetylcholine receptor levels on subpopulations of hippocampal interneurons","volume":"33","author":"Massey","year":"2006","journal-title":"Mol Cell Neurosci"},{"key":"2026092612203774100_ref62","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/ntr\/ntaf060","article-title":"Nicotine improves working memory via augmenting BDNF levels through \u03b17 nAChR: evidence from clinical and preclinical studies","volume":"28","author":"Li","year":"2025","journal-title":"Nicotine Tobacco Res"},{"key":"2026092612203774100_ref63","doi-asserted-by":"publisher","first-page":"36705","DOI":"10.1038\/srep36705","article-title":"Depression-like phenotype by deletion of \u03b17 nicotinic acetylcholine receptor: role of BDNF-TrkB in nucleus accumbens","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"2026092612203774100_ref64","doi-asserted-by":"publisher","first-page":"5611","DOI":"10.1523\/JNEUROSCI.5378-07.2008","article-title":"Postsynaptic action of brain-derived neurotrophic factor attenuates \u03b17 nicotinic acetylcholine receptor-mediated responses in hippocampal interneurons","volume":"28","author":"Fernandes","year":"2008","journal-title":"J Neurosci"},{"key":"2026092612203774100_ref65","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fncel.2020.00082","article-title":"The role of BDNF on neural plasticity in depression","volume":"14","author":"Yang","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"2026092612203774100_ref66","doi-asserted-by":"publisher","first-page":"9857201","DOI":"10.1155\/2016\/9857201","article-title":"Spinal plasticity and behavior: BDNF-induced neuromodulation in uninjured and injured spinal cord","volume":"2016","author":"Garraway","year":"2016","journal-title":"Neuronal Plasticity"},{"key":"2026092612203774100_ref67","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.3390\/pharmaceutics15082081","article-title":"BDNF unveiled: exploring its role in major depression disorder serotonergic imbalance and associated stress conditions","volume":"15","author":"Correia","year":"2023","journal-title":"Pharmaceutics"},{"key":"2026092612203774100_ref68","doi-asserted-by":"publisher","first-page":"1188672","DOI":"10.3389\/fncel.2023.1188672","article-title":"Brain-derived neurotrophic factor (BDNF) has direct anti-inflammatory effects on microglia","volume":"17","author":"Charlton","year":"2023","journal-title":"Front Cell Neurosci"},{"key":"2026092612203774100_ref69","doi-asserted-by":"publisher","first-page":"123796","DOI":"10.1016\/j.lfs.2025.123796","article-title":"BDNF\/TrkB signaling pathway and WDR neurons: Core factors inducing central sensitization of neuropathic pain","volume":"377","author":"Zhong","year":"2025","journal-title":"Life Sci"},{"key":"2026092612203774100_ref70","doi-asserted-by":"publisher","first-page":"111625","DOI":"10.1016\/j.brainresbull.2025.111625","article-title":"Presynaptic BDNF-TrkB signaling contributes to mechanical allodynia in a mouse model of chronic neuropathic pain","volume":"233","author":"Ding","year":"2025","journal-title":"Brain Res Bull"},{"key":"2026092612203774100_ref71","doi-asserted-by":"publisher","first-page":"e23312","DOI":"10.1096\/fj.202301140RR","article-title":"Upregulation of proBDNF\/p75NTR signaling in immune cells and its correlation with inflammatory markers in patients with major depression","volume":"38","author":"Yang","year":"2024","journal-title":"FASEB J"},{"key":"2026092612203774100_ref72","doi-asserted-by":"publisher","first-page":"109767","DOI":"10.1016\/j.intimp.2023.109767","article-title":"ProBDNF signaling is involved in periodontitis-induced depression-like behavior in mouse hippocampus","volume":"116","author":"Li","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"2026092612203774100_ref73","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12974-023-02768-z","article-title":"\u03b17 nicotinic acetylcholine receptor: a key receptor in the cholinergic anti-inflammatory pathway exerting an antidepressant effect","volume":"20","author":"Liu","year":"2023","journal-title":"J Neuroinflammation"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/78\/9\/rgag106\/71403374\/rgag106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/78\/9\/rgag106\/71403374\/rgag106.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:20:44Z","timestamp":1790439644000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/doi\/10.1093\/jpp\/rgag106\/8836673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":73,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgag106","relation":{},"ISSN":["2042-7158"],"issn-type":[{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9,1]]},"article-number":"rgag106"}}